Ligand (LGND) Breakout! | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Ligand (LGND) Breakout!

An SI Board Since September 1996

Posts	SubjectMarks	Bans	Symbol
32384	154	0	LGND

Emcee: Henry Niman	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
30659	Cheryl, I agree that the ONTAK stuff is not big news but I do not think they wi	Gregory Rasp	-	5/24/2000
30658	Soapbox alert! I, for one at least, am not getting excited about Ontak. Tex, a	Cheryl Galt	-	5/24/2000
30657	>>Kind of weird that despite the good news of the last few days, the stoc	Skeeter Bug	-	5/24/2000
30656	Kind of weird that despite the good news of the last few days, the stock is get	J Stone	-	5/24/2000
30655	yes you're right, my mistake. it still seems that the LGND side effects wer	bob zagorin	-	5/24/2000
30654	bob, I believe it is Genentech's anti-VEGF product which is in clinical tri	Gregory Rasp	-	5/24/2000
30653	yes and Genentech's Herceptin, even though it is proving effective with adv	bob zagorin	-	5/24/2000
30652	<I>Side effects observed were asthenia, hyperlipemia, skin scaling and dr	Gregory Rasp	-	5/23/2000
30651	As for the Targetin news, I wonder why the premature halting of the trials. Als	Arthur Radley	-	5/23/2000
30650	Bob, I think this says it all..."``We are continually looking for ways to	Arthur Radley	-	5/23/2000
30649	Henry (or anyone with knowledge), I'd appreciate on this ONTAK story. I rem	bob zagorin	-	5/23/2000
30648	Tuesday May 23, 6:54 pm Eastern Time Biomodulation of ONTAK Increases In Vitro	bob zagorin	-	5/23/2000
30647	Targretin Capsules Shows Activity in Clinical Trials in Patients with Non-Small	bob zagorin	-	5/23/2000
30646	The good news for a change is that LGND appears to have entered into a collabor	J Stone	-	5/22/2000
30645	Bristol-Myers Squibb and Ligand Sign Collaborative Agreement; Targets Hypertens	wolfdog2	-	5/22/2000
30644	Cacaito, NABI is a good prospect; it's a solid company. But you may have	Torben Noerup Nielsen	-	5/19/2000
30643	TexasD, not to worry about this competition, it could actually increase the num	Cacaito	-	5/19/2000
30642	All we need is more competition...http://biz.yahoo.com/bw/000518/pa_collage.htm	Arthur Radley	-	5/18/2000
30641	Longer-Term Use of Panretin Gel for Treatment of Patients with Cutaneous AIDS-R	bob zagorin	-	5/17/2000
30640	td, this sounds like bc speak. depends what you mean by profitability. invest	Skeeter Bug	-	5/17/2000
30639	From annual report..Page(4)"..other products in development pipeline, prov	Arthur Radley	-	5/16/2000
30638	I think the credibility of management relies on breaking even this year. They	Gregory Rasp	-	5/16/2000
30637	will profit failure in 2000 be an excuse to whack lgnd? LGND might get wha	J Stone	-	5/16/2000
30636	what does this do for profitability in 2000? will profit failure in 2000 be an	Skeeter Bug	-	5/16/2000
30635	Skeeter, LGND is simply not going to be able to sell alot of drug to treat CTCL	Gregory Rasp	-	5/16/2000

Go to reply# or date (mm/dd/yy):